The role of implantable cardioverter defibrillators in dilated cardiomyopathy.

@article{Borggrefe1994TheRO,
  title={The role of implantable cardioverter defibrillators in dilated cardiomyopathy.},
  author={Martin Borggrefe and Xu fa Chen and Antoni Mart{\'i}nez-Rubio and Gerd Hindricks and Wilhelm Haverkamp and M. A. Balbo Block and G{\"u}nter Breithardt},
  journal={American heart journal},
  year={1994},
  volume={127 4 Pt 2},
  pages={
          1145-50
        }
}
Depending on the severity of the disease, patients with dilative cardiomyopathy (DCM) have a poor prognosis. No definite data are available to show that complex ventricular ectopy, the presence of ventricular late potentials, or programmed electrical stimulation in patients without symptoms with DCM identify patients at risk of sudden cardiac death. Although poor left ventricular function seems to be the most potent predictor of total cardiac death, the prediction of sudden death in patients… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results

  • Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND